Atara Biotherapeutics
ATRA
#9758
Rank
NZ$60.91 M
Marketcap
$10.40
Share price
-3.43%
Change (1 day)
-65.26%
Change (1 year)

Atara Biotherapeutics (ATRA) - Cash on Hand

Cash on Hand as of December 2024 : NZ$74.63 Million

According to Atara Biotherapeutics's latest financial reports the company has NZ$74.63 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Atara Biotherapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$75.35 M-7.87%
2023-12-31NZ$81.79 M-78.61%
2022-12-31NZ$0.38 B-29.6%
2021-12-31NZ$0.54 B-21.71%
2020-12-31NZ$0.69 B80.35%
2019-12-31NZ$0.38 B-16.65%
2018-12-31NZ$0.46 B97.38%
2017-12-31NZ$0.23 B-36.64%
2016-12-31NZ$0.36 B-21.17%
2015-12-31NZ$0.46 B252.38%
2014-12-31NZ$0.13 B111.56%
2013-12-31NZ$62.81 M1128.2%
2012-12-31NZ$5.11 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$71.01 M-4.85%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$48.92 M-34.45%๐Ÿ‡ฉ๐Ÿ‡ช Germany
NZ$1.06 B 1,324.92%๐Ÿ‡บ๐Ÿ‡ธ USA